Latest Antipsychotic Stories
Lawsuit Help Center reports 2013 Johnson & Johnson settlement of $2.2 billion with U.S. Justice Dept. has caused cases to pile up. PHILADELPHIA, Aug.
Ameritox's Ingenuity Health introduces method to help assess medication adherence in patients prescribed Seroquel XR BALTIMORE, Aug.
First Patient Dosed in the EU Post-Authorization Safety Study MOUNTAIN VIEW, Calif., Aug. 14, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
Risperdal Lawsuit Claims Continue to Be Filed Against Johnson & Johnson Contending Male Breast Growth Due to the Manufacturer’s Antipsychotic Drug Risperdal Reports Wright & Schulte
The Firm is representing Risperdal lawsuit clients who allegedly developed gynecomastia, or male breast growth, due to the use of the antipsychotic medication. New
First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif., Aug. 8, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc.
The Firm is representing a number of Risperdal lawsuit clients who allegedly developed gynecomastia, or male breast growth, due to their use of the atypical antipsychotic drug. New
WOODCLIFF LAKE, N.J. and SAN DIEGO, July 30, 2014 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc.
The Firm is currently representing clients in Risperdal lawsuits that similarly allege the atypical antipsychotic medication caused gynecomastia, a condition categorized by male breast development.
The largest genomic dragnet of any psychiatric disorder to date has unmasked 108 chromosomal sites harboring inherited variations in the genetic code linked to schizophrenia, 83 of which had not been previously reported.
- A trick or prank.